Vera Bradley Reports First Revenue Growth Since FY22, Significantly Reduces Q1 Operating Loss
VRA has more than doubled off its 52-week low of $1.39 on elevated volume (24× avg).
Summary
Vera Bradley reported its first revenue growth since fiscal 2022, with Q1 net revenues up 7.8% and a 74% reduction in operating loss, driven by improved margins and cost controls.
Key Events · Earnings and Guidance · VRA
-
First Revenue Growth Since FY22
Net revenues increased by 7.8% to $55.7 million for the thirteen weeks ended May 2, 2026, compared to $51.7 million in the prior-year period, marking the first revenue growth since Fiscal 2022.
-
Significant Reduction in Operating Loss
Operating loss from continuing operations decreased by 74% to $(4.6) million, a $13.2 million improvement from $(17.9) million in the comparable prior-year period.
-
Improved Gross Profit and Reduced SG&A
Gross profit increased by 26.6% to $28.8 million, with gross margin improving from 44.1% to 51.8%. Selling, general, and administrative expenses decreased by 16.4% to $34.1 million, reflecting successful cost optimization.
-
Reduced Cash Burn from Operations
Net cash used in operating activities significantly decreased to $(5.3) million, an improvement of $12.6 million compared to $(17.9) million in the prior-year period.
Analysis · VRA · Manufacturing
Vera Bradley, Inc. reported a strong first quarter for fiscal 2027, marking its first revenue growth since fiscal 2022. Net revenues increased by 7.8% to $55.7 million, a significant turnaround from the previous fiscal year's declines. The company also dramatically reduced its operating loss from continuing operations by 74% and net loss by 73.6%. This improvement was driven by a substantial increase in gross profit margin (from 44.1% to 51.8%) and a 16.4% reduction in selling, general, and administrative expenses, reflecting successful cost optimization efforts. These results indicate positive momentum from the company's 'Project Sunshine' strategic initiatives, providing a much-needed boost after a challenging period. An ongoing legal dispute regarding a $4.6 million purchase price adjustment from the Pura Vida sale is noted, but the company is actively disputing the claim.
At the time of this filing, VRA was trading at $3.45 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $98M. The 52-week trading range was $1.39 to $4.39. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.